Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). We investigated whether intensive therapy to target normal glycated hemoglobin levels would reduce cardiovascular events in patients with type 2 diabetes who. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
|Published (Last):||22 April 2015|
|PDF File Size:||4.41 Mb|
|ePub File Size:||16.88 Mb|
|Price:||Free* [*Free Regsitration Required]|
UK Prospective Diabetes Study UKPDS was a unique, long-term clinical trial designed to find out how to treat people with Type 2 diabetes to prevent complications and to maintain their health.
Both are important, however, estydio near-normal blood pressure is, in many patients, easier than maintaining near-normal blood glucose levels because more different types of therapies are available. The study showed that intensive blood pressure treatment is acceptable to people with diabetes, and that better blood pressure control than standard management can be obtained. Br J Clin Pharmacol.
The advantages of good care have been more clearly defined than ever before, but the huge gulf between the benefits achieved in the study and the many frustrations of everyday practice remains. UKPDS has shown that, by the time diabetes is diagnosed, approximately half of people with Type 2 diabetes already have evidence of diabetic tissue damage. One diabeets demonstrated that poor quality of life is related to complications rather than the treatments given [unpublished].
Whether intensive glycaemic control ykpds be routinely introduced in type 2 diabetes is more controversial. Effects of enalapril on mortality in severe congestive heart failure.
UK Prospective Diabetes Study : Protocol
One of the first clinical descriptions was by Aretaeus, who practised in Cappadocia around AD. Over 10 years, haemoglobin A1c HbA1c was 7.
On the other hand, the questionnaire showed that when people had diabetic complications, these adversely affected quality of life. One-third of patients allocated to tight control required three more drugs in the attempt to achieve the target blood pressure. Sixteen year follow-up study. New Eng J Med.
For now, until further information is available, clinical practice should be based on achieving glucose and blood pressure reduction by whatever means best suits an individual patient. Therefore indiabeetes additional study was set up in over people with diabetes and a high blood pressure.
Until now there has been little convincing evidence that improved diabetes control will prevent the complications of diabetes. The primary aim was to determine the effect of intensive glycaemic control on the incidence of complications; the secondary aim was to assess whether there were differences between treatments Figure 1. Inthe study of treatment of hypertension was started. Although apparently a “mild form of diabetes” major complications occur, including death from heart attacks and disability including blindness, amputations and kidney failure.
The ACE inhibitor estdio however, better tolerated. This article has been cited by other articles in PMC. New methods of treating diabetes are still diabftes. One thousand one hundred and forty-eight patients took part. There is concern that sulphonylureas may increase cardiovascular mortality in patients with type 2 diabetes and that high insulin concentrations may enhance atheroma formation.
The benefits of treatment? The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. McCarty D, Zimnet P. Kluwer Academic publishers; Mortality and survival in type II non-insulin dependent diabetes mellitus.
The main questions were:.
UK Prospective Diabetes Study
With the increasing prevalence of the condition, these figures will escalate. Over subjects at 23 centres across the UK were ujpds for inclusion; took part. UKPDS showed conclusively that in people with improved blood glucose control the risk was reduced of:. Collins R, Macmahon S. Patients also develop cataracts requiring surgery.
A variety of agents was used, but blood pressure differences between treatment and control groups were comparable with the UKPDS, and protective effects were observed despite shorter periods of follow up 2—5 years.
Others were allocated to an intensive policy group aiming for near-normal glucose control, with two different sulphonylureas tablets or to insulin. Economic evaluations of Type II diabetes. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: However, glucose levels usually remain high and these can lead to “diabetic complications”.
In people with Type 2 diabetes that is usually diagnosed in middle age, symptoms can often be controlled estudi diet or tablet therapy. That the reduced occurrence of myocardial infarction was not significant may be due to type 2 statistical error. Renal protective effects in diabetic nephropathy. Within nine years approximately one-third of patients required three different types of treatment.
These strengthened the study by broadening its scope, but at the cost of complicating the treatment allocation, conduct and analysis of the study. The same diabetds ascertainment and adjudication process was used throughout to ensure analytic comparability. Erratum in Lancet Aug 14; Author information Article notes Copyright and License information Disclaimer.